Abstract
Pharmacological activation of the P2X4 receptor expressed by brain microglia may provide a novel avenue to promote remyelination and improve clinical symptoms in experimental autoimmune encephalomyelitis and potentially in multiple sclerosis. EMBO Mol Med (2018) 10: e9369
Cite
CITATION STYLE
APA
Di Virgilio, F., & Sarti, A. C. (2018). Microglia P2X4 receptors as pharmacological targets for demyelinating diseases. EMBO Molecular Medicine, 10(8). https://doi.org/10.15252/emmm.201809369
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free